Taiwan Advance Bio-Pharmaceutical Intangible Assets

As of the most recent data (June 2026), 4186.TWO shows a intangible assets of $160K. That compares with $190K in the prior-year period — down 11.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4186.TWO's intangible assets is now $160K (was $190K) — a 11.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Taiwan Advance Bio-Pharmaceutical is outperforming or lagging.

Tracking 4186.TWO's intangible assets over time shows whether Taiwan Advance Bio-Pharmaceutical is scaling, shrinking, or reshaping that part of the business. The current reading is $160K That compares with $190K in the prior-year period — down 11.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Taiwan Advance Bio-Pharmaceutical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $160K) with ownership activity and broader fundamentals.

Taiwan Advance Bio-Pharmaceutical's intangible assets is $160K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.